Ustekinumab(ustekinumab) is an interleukin inhibitor. Ustekinumab is approved by FDAApproved for the treatment of moderate or severe psoriasis(patients 6 years and older), psoriatic arthritis(Patients 18 years old and above), moderately to severely active Crohn's disease(Patients 18 years old and above ), moderate to severe active ulcerative colitis (patients 18 years old and above ). Ustekinumab side effects>10%The incidence rate of side effects1-10%includes nasopharyngitis, back pain, cellulitis, depression, diarrhea, fatigue, headache, injection site erythema, myalgia, fatigue, nasal congestion, urticaria, itching, antibody formation, etc. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.
.jpeg)
